Subscribe
mihailgrey
mihailgrey / iStockphoto.com
12 February 2018Americas

Merck Sharp & Dohme fails to secure new nasal spray trial

The US Court of Appeals for the Federal Circuit denied Merck Sharp & Dohme’s (MSD) request for a new trial to determine whether Amneal infringed a patent related to a nasal spray on Friday, February 9.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Generics
Bayer, Meda sue Apotex over nasal spray
12 October 2021   Bayer Healthcare and drug importer Meda Pharmaceuticals have sued generic manufacturer Apotex, alleging that its planned generic nasal spray infringes on Bayer’s Astepro patents.


Editor's picks

BMS blocks biosimilar version of blockbuster cancer drug in India
Americas
BMS blocks biosimilar version of blockbuster cancer drug in India
21 July 2025

Editor's picks

Americas
BMS blocks biosimilar version of blockbuster cancer drug in India
21 July 2025
Africa
Explainer: ARIPO’s role in Plant Variety Protection
15 July 2025
Europe
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025
Europe
‘We created law’: G1/24 and the creation of the ‘diamond standard’
3 July 2025
Americas
Bankruptcy judge approves $305m sale of genetics testing company
1 July 2025
Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025

More on this story

Generics
Bayer, Meda sue Apotex over nasal spray
12 October 2021   Bayer Healthcare and drug importer Meda Pharmaceuticals have sued generic manufacturer Apotex, alleging that its planned generic nasal spray infringes on Bayer’s Astepro patents.

More on this story

Generics
Bayer, Meda sue Apotex over nasal spray
12 October 2021   Bayer Healthcare and drug importer Meda Pharmaceuticals have sued generic manufacturer Apotex, alleging that its planned generic nasal spray infringes on Bayer’s Astepro patents.

More features

Could Apple v Masimo limit patent cases at the ITC?
Eli Lilly strikes again in weight-loss drugs fight
Novartis moves to block cancer drug generic in US
WATCH: China patent landscape—AI, patent linkage, export controls, and more
China bars USPTO employee from leaving country
UPC hands rare default win to Insulet, bans insulin pump in EU
GSK loses appeal over purple inhaler TM in Europe
Astellas defends Xtandi patent as court rejects generics’ appeal